Indole sulfonamide modulators of progesterone receptors

DODGE JEFFREY ALAN, LOPEZ JOSE EDUARDO, BLEISCH THOMAS JOHN, CLARKE CHRISTIAN ALEXANDER, JONES SCOTT ALAN, LUGAR CHARLES WILLIS III, Muehl Brian Stephen, RICHARDSON TIMOTHY IVO, YEE YING KWONG, YU KUO-LONG
2011
OA: closed Metadata only
⚙ AI-generated summary by qwen3.7-flash, 2026-09-13 ⓘ

The authors disclose an indole sulfonamide compound, its pharmaceutical composition, and preparation method for use in treating or preventing leiomyomas and endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Disclosed is an indole sulphonamide compound of formula (I) wherein the substituents are as described in the disclosure. Also disclosed is a pharmaceutical composition comprising a compound of formula (I) and a method for preparing a compound of formula (I). Further disclosed is the use of a compound of formula (I) in the manufacture of a medicament for treating or preventing leiomyomas and endometriosis in a mammal.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-09-06T09:34:12.023084+00:00